Incidence, severity and treatment outcome of tuberculosis in the era of the COVID-19 pandemic, France, 2018-2023.

Publication date: Feb 01, 2025

In France, the average steady decline in tuberculosis (TB) incidence close to 5 % per year over the past half-century has been occasionally interrupted by disruptions related to external events. We describe the impact of the COVID-19 pandemic on TB incidence, severity and treatment outcome. We analysed the number of TB cases and treatment outcomes reported through the mandatory notification system through 2018-2023. We compared cases reported, notification rates and percentage of cases completing treatment before and after the occurrence of the COVID-19 pandemic. The TB rate and the mean weekly number of cases decreased from 7. 6/100,000 to 6. 8/100,000 (-10 %) (p=0. 96) between 2019 and 2020. This decreasing trend continued, albeit more moderately, in 2021 (-7 %) and 2022 (-2 %). The trend shifted upward in 2023 (7. 1/100,000, +15 % compared to 2022). The mean weekly number of reported cases significantly decreased between 2018 (n=97), 2019 (n=97) and 2020 (n= 88) (p

Concepts Keywords
France Adult
Occasionally Aged
Tuberculosis Antitubercular Agents
Antitubercular Agents
COVID-19
Covid-19
Epidemiology
Female
France
France
Humans
Incidence
Male
Middle Aged
Pandemics
SARS-CoV-2
Surveillance
Treatment Outcome
Tuberculosis
Tuberculosis

Semantics

Type Source Name
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH COVID-19 pandemic

Original Article

(Visited 1 times, 1 visits today)